I'm gonna talk about the early signs of ovarian cancer. Now what's unique about the ovarian cancer

is this. It's one of the most lethal types of cancer that involves female reproductive organs.

Over 300,000 women get this cancer every single year in the US and 200,000 of them don't make it.

So early detection or even prevention is the key. But before I get into it, I really need to tell

you something. And this involves the decision of whether or not to get chemotherapy.

Now just realize I'm not telling you to do one way or the other, I just want to give you the

data. And there's some important data that you need to have to make the best decision,

and unfortunately it's very difficult to get. And I'm gonna put this study down below,

but you need to check this out. Now this study was done at the Department of Radiation on

Ecology at Northern Sydney Cancer Center. And it was actually published in a journal called

Clinical Oncology. And they were looking at the actual impact of chemo on survival rates within

five years. Now it's interesting to me that they everything related to cancer is like kind of five

year survival rate. If you make it to that point, you're considered a success. And this relates

to American adults that get cancer. This is what they found. The people that opt for chemo only have

a 2.1% increase in survival compared to people who don't opt for chemo. And I know you're saying it's

well, it's an improvement. It's 2.1%. But in actuality, that is a very, very small improvement.

However, when you look at the data that extends beyond five years, things are completely different.

Okay, let me explain. Dr. Hardin Jones, Professor of Medical Physics and Physiology at Berkeley,

California, looked at data way past this five year survival rate. He looked at 25 years. He

wondered, understand what happens with people that get chemo and people that don't get chemo

over a 25 year span. And this is what he found. People who refuse chemo actually lived 12.5 years

longer than people that did get chemo. That's incredible data. But this is my this claim. I'm

...